Avantra Family Wealth Inc. Decreases Position in Koninklijke Philips N.V. $PHG

Avantra Family Wealth Inc. decreased its stake in Koninklijke Philips N.V. (NYSE:PHG) by 8.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,839 shares of the technology company’s stock after selling 1,558 shares during the period. Avantra Family Wealth Inc.’s holdings in Koninklijke Philips were worth $404,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Fiduciary Management Inc. WI boosted its holdings in Koninklijke Philips by 21.7% in the first quarter. Fiduciary Management Inc. WI now owns 7,515,737 shares of the technology company’s stock valued at $190,900,000 after purchasing an additional 1,339,055 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Koninklijke Philips by 2.5% in the first quarter. Dimensional Fund Advisors LP now owns 4,396,095 shares of the technology company’s stock valued at $111,662,000 after purchasing an additional 106,044 shares during the last quarter. Northern Trust Corp boosted its holdings in Koninklijke Philips by 5.1% in the first quarter. Northern Trust Corp now owns 1,690,402 shares of the technology company’s stock valued at $42,936,000 after purchasing an additional 81,653 shares during the last quarter. Perpetual Ltd boosted its holdings in Koninklijke Philips by 2.6% in the second quarter. Perpetual Ltd now owns 872,646 shares of the technology company’s stock valued at $20,926,000 after purchasing an additional 21,898 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its holdings in Koninklijke Philips by 1.5% in the first quarter. Goldman Sachs Group Inc. now owns 846,253 shares of the technology company’s stock valued at $21,495,000 after purchasing an additional 12,908 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Trading Up 0.1%

Shares of NYSE PHG opened at $28.04 on Tuesday. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.69. The stock’s 50 day moving average price is $27.48 and its two-hundred day moving average price is $25.19. The stock has a market capitalization of $27.00 billion, a P/E ratio of 147.58, a PEG ratio of 0.74 and a beta of 0.82. Koninklijke Philips N.V. has a 52-week low of $21.48 and a 52-week high of $32.62.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings results on Tuesday, July 29th. The technology company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.12. The business had revenue of $5.05 billion for the quarter, compared to analysts’ expectations of $4.35 billion. Koninklijke Philips had a return on equity of 11.95% and a net margin of 1.00%. On average, analysts anticipate that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently commented on PHG shares. Weiss Ratings reissued a “sell (d+)” rating on shares of Koninklijke Philips in a report on Saturday, September 27th. Wall Street Zen downgraded Koninklijke Philips from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.